Yüklüyor......
Monitoring response and resistance to treatment in chronic myeloid leukemia
Chronic myeloid leukemia (cml) results from expression of the constitutive tyrosine kinase activity of the Bcr-Abl oncoprotein. Imatinib, a tyrosine kinase inhibitor (tki), is highly effective in the treatment of cml. However, some patients treated with imatinib will fail to respond, will respond su...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Multimed Inc.
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3070714/ https://ncbi.nlm.nih.gov/pubmed/21505592 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|